{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T10:55:00Z","timestamp":1770288900744,"version":"3.49.0"},"reference-count":34,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Exp Ther Med"],"DOI":"10.3892\/etm.2018.6358","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T07:11:29Z","timestamp":1530083489000},"source":"Crossref","is-referenced-by-count":1,"title":["Combination of catheter ablation for non\u2011valvular atrial fibrillation and left atrial appendage occlusion in a single procedure"],"prefix":"10.3892","author":[{"given":"Xuexun","family":"Li","sequence":"first","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongxia","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihong","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangqiang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaofei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Yantai Yuhuangding Hospital, Yantai, Shandong 264000, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2018,6,27]]},"reference":[{"key":"key20200713114414_b1-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1093\/europace\/euq350","article-title":"Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"12","author":"Camm","year":"2010","journal-title":"Europace"},{"key":"key20200713114414_b2-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The AnTicoagulation and risk factors in atrial fibrillation (ATRIA) study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"key20200713114414_b3-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/heart.86.5.516","article-title":"Population prevalence, incidence, and predictors of atrial fibrillation in the Renfrew\/Paisley study","volume":"86","author":"Stewart","year":"2001","journal-title":"Heart"},{"key":"key20200713114414_b4-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","article-title":"Heart disease and stroke statistics - 2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"key20200713114414_b5-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1161\/01.CIR.0000140263.20897.42","article-title":"Lifetime risk for development of atrial fibrillation: The Framingham Heart Study","volume":"110","author":"Lloyd-Jones","year":"2004","journal-title":"Circulation"},{"key":"key20200713114414_b6-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/S0894-7317(99)70105-7","article-title":"Pathophysiologic correlates of thromboembolism in nonvalvular atrial fibrillation: I. Reduced flow velocity in the left atrial appendage (The stroke prevention in atrial fibrillation (SPAF-III) study)","volume":"12","author":"Goldman","year":"1999","journal-title":"J Am Soc Echocardiogr"},{"key":"key20200713114414_b7-etm-0-0-6358","first-page":"50","article-title":"2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"70","author":"Kirchhof","year":"2017","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"key20200713114414_b8-etm-0-0-6358","doi-asserted-by":"crossref","first-page":"244","DOI":"10.18553\/jmcp.2009.15.3.244","article-title":"Meta-analysis to assess the quality of warfarin control in atrial fibrillation patients in the United States","volume":"15","author":"Baker","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"key20200713114414_b9-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1161\/CIRCULATIONAHA.106.653048","article-title":"Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation","volume":"115","author":"Hylek","year":"2007","journal-title":"Circulation"},{"key":"key20200713114414_b10-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1093\/europace\/eur126","article-title":"Bleeding risk assessment and management in atrial fibrillation patients: A position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis","volume":"13","author":"Lip","year":"2011","journal-title":"Europace"},{"key":"key20200713114414_b11-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/S0140-6736(09)61343-X","article-title":"PROTECT AF Investigators: Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: A randomised non-inferiority trial","volume":"374","author":"Holmes","year":"2009","journal-title":"Lancet"},{"key":"key20200713114414_b12-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/CIRCULATIONAHA.110.976449","article-title":"Safety of percutaneous left atrial appendage closure: Results from the Watchman left atrial appendage system for embolic protection in patients with AF (PROTECT AF) clinical trial and the continued access registry","volume":"123","author":"Reddy","year":"2011","journal-title":"Circulation"},{"key":"key20200713114414_b13-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1161\/CIRCULATIONAHA.112.114389","article-title":"PROTECT AFInvestigators: Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year follow-up of the PROTECT AF (Watchman left atrial appendage system for embolic protection in patients with atrial fibrillation) trial","volume":"127","author":"Reddy","year":"2013","journal-title":"Circulation"},{"key":"key20200713114414_b14-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","article-title":"Validation of clinical classification schemes for predicting stroke: Results from the National Registry of Atrial Fibrillation","volume":"285","author":"Gage","year":"2001","journal-title":"JAMA"},{"key":"key20200713114414_b15-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1378\/chest.09-1584","article-title":"Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: The euro heart survey on atrial fibrillation","volume":"137","author":"Lip","year":"2010","journal-title":"Chest"},{"key":"key20200713114414_b16-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: The HAS-BLED (hypertension, abnormal renal\/liver function, stroke, bleeding history or predisposition, labile INR, elderly, drugs\/alcohol concomitantly) score","volume":"57","author":"Lip","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"key20200713114414_b17-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ahj.2006.02.005","article-title":"The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in patients with atrial fibrillation) trial","volume":"151","author":"Fountain","year":"2006","journal-title":"Am Heart J"},{"key":"key20200713114414_b18-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ijcard.2016.06.041","article-title":"Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: The PREVAIL trial","volume":"219","author":"Belgaid","year":"2016","journal-title":"Int J Cardiol"},{"key":"key20200713114414_b19-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1016\/j.jacc.2013.01.061","article-title":"Quality of life assessment in the randomized PROTECT AF (percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation) trial of patients at risk for stroke with nonvalvular atrial fibrillation","volume":"61","author":"Alli","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"key20200713114414_b20-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1093\/eurheartj\/ehu001","article-title":"The atrial fibrillation ablation pilot study: A European Survey on Methodology and results of catheter ablation for atrial fibrillation conducted by the European Heart Rhythm Association","volume":"35","author":"Arbelo","year":"2014","journal-title":"Eur Heart J"},{"key":"key20200713114414_b21-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/europace\/eus027","article-title":"2012 HRS\/EHRA\/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design","volume":"14","author":"Calkins","year":"2012","journal-title":"Europace"},{"key":"key20200713114414_b22-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1093\/eurheartj\/eht457","article-title":"Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: A multicentre, randomized, controlled trial (SARA study)","volume":"35","author":"Mont","year":"2014","journal-title":"Eur Heart J"},{"key":"key20200713114414_b23-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1093\/europace\/euu342","article-title":"Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation: Results on health-related quality of life and symptom burden. The MANTRA-PAF trial","volume":"17","author":"Walfridsson","year":"2015","journal-title":"Europace"},{"key":"key20200713114414_b24-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"e003337","DOI":"10.1161\/CIRCEP.115.003337","article-title":"Gap-AF-AFNET 1 Investigators*: Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: Results from the gap-atrial fibrillation-German atrial fibrillation competence network 1 trial","volume":"9","author":"Kuck","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"key20200713114414_b25-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1812","DOI":"10.1093\/eurheartj\/ehv139","article-title":"A minimal or maximal ablation strategy to achieve pulmonary vein isolation for paroxysmal atrial fibrillation: A prospective multi-centre randomized controlled trial (the Minimax study)","volume":"36","author":"McLellan","year":"2015","journal-title":"Eur Heart J"},{"key":"key20200713114414_b26-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ahj.2012.04.002","article-title":"Substrate and trigger ablation for reduction of atrial fibrillation trial-part II (STAR AF II): Design and rationale","volume":"164","author":"Verma","year":"2012","journal-title":"Am Heart J"},{"key":"key20200713114414_b27-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1161\/CIRCULATIONAHA.115.016871","article-title":"Cryoballoon versus open irrigated radiofrequency ablation in patients with paroxysmal atrial fibrillation: The prospective, randomized, controlled, noninferiority freezeaf study","volume":"132","author":"Luik","year":"2015","journal-title":"Circulation"},{"key":"key20200713114414_b28-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jce.12267","article-title":"Cryoballoon versus RF ablation in paroxysmal atrial fibrillation: Results from the German Ablation Registry","volume":"25","author":"Schmidt","year":"2014","journal-title":"J Cardiovasc Electrophysiol"},{"key":"key20200713114414_b29-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1161\/CIRCOUTCOMES.111.963108","article-title":"Health outcomes with catheter ablation or antiarrhythmic drug therapy in atrial fibrillation: Results of a propensity-matched analysis","volume":"5","author":"Reynolds","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"key20200713114414_b30-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.joa.2015.11.001","article-title":"Combined catheter ablation for atrial fibrillation and Watchman\u00ae left atrial appendage occlusion procedures: Five-year experience","volume":"32","author":"Phillips","year":"2016","journal-title":"J Arrhythm"},{"key":"key20200713114414_b31-etm-0-0-6358","first-page":"687","article-title":"Combined catheter ablation for atrial fibrillation and watchman\u00ae left atrial appendage occlusion procedures: A single centre experience","volume":"5","author":"Walker","year":"2012","journal-title":"J Atr Fibrillation"},{"key":"key20200713114414_b32-etm-0-0-6358","first-page":"1346","article-title":"Ablation of atrial fibrillation in combination with left atrial appendage occlusion in a single procedure. Rationale and technique","volume":"8","author":"Bolao","year":"2016","journal-title":"J Atr Fibrillation"},{"key":"key20200713114414_b33-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.4244\/EIJY14M09_18","article-title":"EHRA\/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion","volume":"10","author":"Meier","year":"2015","journal-title":"EuroIntervention"},{"key":"key20200713114414_b34-etm-0-0-6358","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1161\/CIRCULATIONAHA.109.928903","article-title":"Left atrial appendage: An underrecognized trigger site of atrial fibrillation","volume":"122","author":"Di Biase","year":"2010","journal-title":"Circulation"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"deposited":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T13:41:02Z","timestamp":1661521262000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/etm.2018.6358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":34,"URL":"https:\/\/doi.org\/10.3892\/etm.2018.6358","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,27]]}}}